Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals
AssigneeARYx Therapeutics, Inc.
InventorsPascal Druzgala, Peter G. Milner
Life of this patent
Estimating the term…
Abstract
The subject invention provides pharmaceutical compounds useful in the treatment of Type II diabetes. These compounds are advantageous because they are readily metabolized by the metabolic drug detoxification systems. Particularly, isoxazolidine compounds which have been designed to include esters within the structure of the compounds are provided. This invention is also drawn to methods of treating disorders, such as diabetes, comprising the administration of therapeutically effective compositions comprising compounds which have been designed to be metabolized by serum or intracellular hydrolases and esterases. Pharmaceutical compositions of the isoxazolidine compounds are also taught.
Claims5
A compound comprising
- wherein:
- A is N11 and B is C═O or;
- F is O;
- D1-D6 are C;
- E is 11;
- P and Q can be a double bond or H;
- X is
- and analogs, derivatives, or salts of the compound of Formula I.
A composition comprising a carrier and a compound comprising
- wherein:
- A is N11 and B is C═O;
- F is O;
- D1-D6 are C;
- E is 11;
- P and Q can be a double bond or H;
- X is
- and analogs, derivatives, or salts of the compound of Formula I.
A method of treating diabetes, atherosclerosis, hypercholesterolemia, or hyperlipidemia comprising the administration of a therapeutically effective amount of the composition comprising a carrier and a compound comprising
- wherein:
- A is N11 and B is C═O;
- F is O;
- D1-D6 are C;
- E is 11;
- P and Q can be a double bond or H;
- X is
- and analogs, derivatives, or salts of the compound of Formula I.
Dependencies are inferred from the claim text.